SIBO Breath Test: How to Interpret Your Result

What the SIBO Breath Test Actually Measures

The test captures gases produced when gut bacteria ferment a sugar substrate you drink after an overnight fast. Human cells cannot make hydrogen or methane. Any H2 or CH4 detected in exhaled breath comes from bacterial metabolism, meaning elevated readings directly reflect microbial activity somewhere along the gut.

After you swallow the substrate (usually lactulose or glucose), it travels down the gastrointestinal tract. If bacteria have colonized the small intestine in abnormally high concentrations (defined as greater than 10^3 colony-forming units per mL of jejunal aspirate in the most cited culture studies), they ferment the sugar before it reaches the colon, producing an early gas peak. [1]

Exhaled breath samples are collected at baseline and then at 15 to 20 minute intervals for 120 to 180 minutes total. The resulting printout is a time-versus-ppm curve, and its shape tells the interpreting clinician far more than any single number.

Why Two Gases Are Reported

Hydrogen-producing bacteria (predominantly Gram-negative anaerobes) generate H2 directly from carbohydrate fermentation. A separate group of archaea, primarily Methanobrevibacter smithii, then consumes H2 and produces CH4 as a byproduct. [2] Because these two microbial populations behave differently and respond to different antibiotics, labs now routinely report both gases side by side.

Some labs also report hydrogen sulfide (H2S), though validated consensus thresholds for H2S had not been formally established as of the 2017 North American Consensus publication. [3]

The Role of the Substrate

Lactulose is a non-absorbable disaccharide. Because the small intestine cannot absorb it, it reaches the colon regardless, which means a late rise in gas (after 90 to 120 minutes) may simply reflect normal colonic fermentation rather than SIBO. Glucose, by contrast, is rapidly absorbed in the proximal small intestine, so any fermentation-related gas peak almost certainly originates there. Glucose has higher specificity but misses bacteria living in the distal small intestine. [4] The choice of substrate changes how you interpret the timing of any gas rise.

Normal SIBO Breath Test Ranges

A normal result shows a low, flat curve throughout the test. Specific numerical thresholds below come from the 2017 North American Consensus statement published in Clinical Gastroenterology and Hepatology. [3]

Hydrogen (H2) Normal Values

• Fasting baseline H2: <20 ppm
• Maximum rise from baseline during the first 90 minutes: <20 ppm
• A rise of ≥20 ppm above the lowest pre-rise value within 90 minutes of substrate ingestion = positive for SIBO

The 90-minute cutoff is specific to lactulose. For glucose substrate, any H2 rise of ≥20 ppm above baseline at any point is considered positive because glucose should not reach the colon at all. [3]

Methane (CH4) Normal Values

Methane thresholds differ because CH4-producing archaea are not universally present. The 2017 consensus defined intestinal methanogen overgrowth (IMO) as a methane value of ≥10 ppm at any single time point during the test, including baseline. [3]

Patients whose dominant gas is methane rather than hydrogen tend to present with constipation rather than diarrhea, a pattern supported by a controlled study (n=93) showing significantly slower whole-gut transit times in methane-positive participants compared with methane-negative controls (P<0.05). [5]

Baseline Values and Prep Failures

A fasting baseline H2 at or above 20 ppm is a red flag. It may indicate the patient ate fermentable foods the day before the test, did not fast for the full 12 hours, recently used a laxative, or has severe colonic dysmotility producing retrograde gas signal. Most labs will flag this and request a repeat under better prep conditions.

How to Read a Positive Result

Interpreting a positive result requires you to look at three variables simultaneously: which gas rose, when it rose, and how high it went. The table below summarizes the four most clinically meaningful patterns.

| Pattern | Gas | Timing of Rise | Clinical Implication | |---|---|---|---| | Early H2 peak | H2 | Within 90 min (lactulose) or any time (glucose) | Hydrogen-dominant SIBO, often diarrhea-predominant | | Elevated baseline CH4 | CH4 | At time zero or early | IMO, often constipation-predominant | | Dual gas rise | H2 then CH4 | H2 early, CH4 following | Mixed SIBO/IMO, may need dual antibiotic therapy | | Late-only rise | H2 | After 90 to 120 min | Normal colonic fermentation, not diagnostic for SIBO |

A single data point rarely closes the diagnosis. The 2017 North American Consensus explicitly states that breath test results "should be interpreted in the context of the patient's symptoms and clinical history." [3] A positive number on a printout without a matching symptom burden warrants caution before prescribing antibiotics.

What a High Hydrogen Reading Means

An H2 rise of 20 to 40 ppm above baseline represents a mild-to-moderate positive. Rises above 40 ppm above baseline are strongly positive and correlate with higher bacterial loads in culture-comparison studies. [6] Symptom overlap between SIBO and irritable bowel syndrome (IBS) is substantial: a meta-analysis of 12 studies (n=1,921 patients) found SIBO breath test positivity in 54% of IBS patients versus 32% of healthy controls (pooled OR 4.46, 95% CI 1.69 to 11.8). [7]

High H2 with an early peak in the first 60 minutes is particularly specific for small-bowel overgrowth rather than colonic fermentation artifact, especially when glucose substrate was used.

What a High Methane Reading Means

Methane at or above 10 ppm at any time point meets the IMO threshold. [3] Values of 10 to 20 ppm are common in patients with slow-transit constipation, while values above 20 ppm have been associated with more severe constipation and, in some studies, with increased risk of diverticular disease. [8]

Because methanogenic archaea are not technically bacteria, rifaximin alone has lower efficacy against IMO. A randomized controlled trial (n=119) found that combining rifaximin 550 mg three times daily with neomycin 500 mg twice daily for 14 days produced significantly higher eradication rates for methane-positive patients compared with rifaximin alone (87.1% vs. 33.3%, P<0.001). [9]

What a Low or Flat Result Means

A low, flat curve throughout the entire test suggests one of three scenarios: no SIBO is present; bacterial load is below the detection threshold of the breath test; or a technical factor suppressed gas production. Sensitivity limitations are real. A systematic review comparing breath testing against jejunal culture (the historical reference standard) found breath test sensitivity ranging from 30% to 78% depending on methodology, substrate, and threshold used. [4]

Factors that can produce a false-negative result include antibiotic use within the past 4 weeks, recent bowel prep or colonoscopy, proton-pump inhibitor use (which reduces gastric acid and may alter small-bowel flora composition), and rapid orocecal transit that carries the substrate to the colon before bacteria have time to ferment it significantly. [3]

Factors That Affect Your Result

Several variables outside your bacterial load can shift the numbers up or down. Understanding them prevents over-treatment of artifacts and under-treatment of real overgrowth.

Diet the Day Before

The prep diet for a SIBO breath test requires avoidance of all fermentable carbohydrates for 24 hours before the test. This means no grains, no high-fiber vegetables, no legumes, and no dairy. A prep-diet failure does not always produce a falsely elevated baseline. It can produce a spurious early H2 peak that mimics SIBO when fermentable residue sits in the proximal gut. Most laboratories provide a specific low-fermentation diet sheet, and adherence should be confirmed before interpreting any borderline result.

Medications and Gut Motility

Opioids slow orocecal transit and may delay gas peaks, turning what would be an early positive into a late (and therefore ambiguous) rise. Prokinetics such as low-dose naltrexone or metoclopramide accelerate transit and can shift gas peaks earlier. [10] Any medication that alters gut flora, motility, or gastric acid should be noted on the test requisition.

Smoking and Exercise on Test Day

Smoking and vigorous exercise both affect alveolar gas exchange and can artifactually alter exhaled gas concentrations. Standard protocol requires patients to rest quietly and avoid smoking for the entire test duration. [3]

How to Lower a High SIBO Breath Test Result

A persistently elevated breath test after a first treatment course is common. Published eradication rates with a single 14-day course of rifaximin range from 49% to 70% depending on patient selection. [11]

First-Line Antibiotic Options

For hydrogen-dominant SIBO, rifaximin 550 mg three times daily for 14 days remains the best-studied regimen. The drug is minimally absorbed, acts locally in the gut lumen, and carries a low risk of systemic side effects. A randomized trial (n=124) demonstrated that rifaximin achieved a negative breath test in 70.8% of hydrogen-SIBO patients versus 27.3% placebo (P<0.001). [11]

For methane-dominant IMO, rifaximin combined with neomycin or with metronidazole 250 mg three times daily for 14 days shows higher eradication rates than rifaximin alone, as noted above. [9]

Elemental Diet as an Alternative

A 2-week course of an elemental formula (complete pre-digested nutrition that bypasses bacterial fermentation) has shown SIBO eradication rates of approximately 80% in an observational study of 93 patients, comparable to antibiotic therapy. [12] Elemental diet is sometimes preferred when antibiotic resistance is a concern or when patients cannot tolerate rifaximin.

Addressing the Root Cause

Treating SIBO without identifying the predisposing condition leads to rapid recurrence. Common drivers include hypochlorhydria, impaired migrating motor complex function (which normally sweeps bacteria from the small bowel between meals), structural abnormalities such as adhesions or strictures, and conditions like hypothyroidism or diabetes that slow motility. [13] A gastroenterologist evaluation is warranted when SIBO recurs within 3 months of a successful treatment course.

How to Raise a Low SIBO Breath Test Result

A low reading is generally good news, but if your symptoms persist despite a negative test, consider whether the test was performed correctly and whether an alternative diagnosis explains your symptoms.

Repeating After Correcting Prep Errors

The single most actionable step after a negative test with ongoing symptoms is to repeat the test with strict adherence to the prep diet and a confirmed 12-hour fast. A telehealth review of the specific foods eaten the day before and any medications taken should happen before ordering a repeat.

Choosing the Right Substrate

If your first test used glucose substrate and was negative, a lactulose-substrate repeat may detect overgrowth in the mid-to-distal small bowel that glucose testing missed. The two substrates have complementary sensitivity profiles, and some guidelines recommend sequential testing in high-clinical-suspicion cases. [4]

When SIBO Is Not the Diagnosis

Persistent symptoms with repeatedly negative tests should prompt evaluation for other conditions: exocrine pancreatic insufficiency, bile acid malabsorption, celiac disease, or carbohydrate intolerance syndromes (lactose, fructose, sorbitol). A 2020 prospective cohort study (n=340) found that 38% of patients referred for SIBO breath testing who tested negative were ultimately diagnosed with functional bowel disorders that improved with low-FODMAP dietary intervention rather than antibiotics. [14]

After Treatment: Retesting and Follow-Up

Most clinicians retest 2 to 4 weeks after completing antibiotic therapy. A negative post-treatment breath test confirms eradication and allows dietary liberalization. A persistently positive result after two treatment courses should trigger referral to a gastroenterologist with expertise in small-bowel motility disorders.

The American College of Gastroenterology notes in its 2020 IBS guideline that rifaximin is the only antibiotic with Level 1A evidence for non-constipation IBS, a population with high SIBO breath test positivity rates, and recommends re-treatment for patients who respond initially but relapse. [15]

Prokinetic therapy between antibiotic courses, such as low-dose erythromycin 50 mg at bedtime or prucalopride 1 mg daily, may reduce recurrence by restoring migrating motor complex function, though large RCT data in SIBO specifically remain limited. [10]